Patents/Assignees

INSTITUTO BUTANTAN

2 patents in portfolio

US12329806utility2025
Compound for Modulating Rlr, Tlr, Oas And/or Oncostatin M Pathways, Use Thereof for Preparing a Medicine, Composition, Method for Modulating Said Pathways and Method of Treatment
0 cites
US12303547utility2025
Compound, Use, Pharmaceutical Composition, Method of Diagnosis, Method of Treatment, and Method of Transportation And/or Internalization of a Compound Into Eukaryotic Cells
0 cites